- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0004270

About Vasista Life Sciences Private Limited
Data last updated:
Vasista Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC067618. Its GSTIN is 36AADCV2601C1ZW (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Potturi Narayana Raju (Managing Director) and Ganapathi Raju Venkataappala Narasimha Varma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D No 11 – 6 – 53/2/5 Opp:Idpl Main Gate Beside Line To M R Steels Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹162.88 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Cr (net margin 0.6%) and EBITDA of ₹12.4 Cr (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 23% over five years.
The company has about 42 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Vasista Life Sciences. As per MCA filings, the company has open charges of ₹11.51 Cr and satisfied charges of ₹18.84 Cr on record. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Flawless Pharma Private Limited with revenue of ₹167.18 Cr. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 24 micro and small suppliers.
Vasista Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004270). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vasista.co.in.
CIN History of Vasista Life Sciences Private Limited
Vasista Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2010PTC067618. The current CIN is U24232TG2010PTC067618, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC067618 | Current |
| U24232AP2010PTC067618 | Previous |
Recognitions & Rankings of Vasista Life Sciences
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressD No 11 – 6 – 53/2/5 Opp:Idpl Main Gate Beside Line To M R Steels Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Vasista Life Sciences Private Limited
Vasista Life Sciences operates one associated brand: Vasista Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies active pharmaceutical ingredients, intermediates, and specialty chemicals. | vasistalife.com |
Business Activity of Vasista Life Sciences Private Limited
The main business activity of Vasista Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vasista Life Sciences Private Limited FY 2025 filings available
Vasista Life Sciences Private Limited reported revenue of ₹162.88 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vasista Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 19% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vasista Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.4 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.05 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vasista Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vasista Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vasista Life Sciences Private Limited
Vasista Life Sciences has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganapathi Raju Venkataappala Narasimha Varma | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Satya Bangara Srirama Chandra Varma Kanumuri | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Potturi Akhil Varma | Additional Director | 28 Nov 2022 | 3 Years 10 Months | Current |
| Raja Rajeswari Potturi | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Potturi Narayana Raju | Managing Director | 19 Mar 2010 | 16 Years 7 Months | Current |
| Yerramsetty Srinivasan | Director | 24 Aug 2021 | 5 Years 1 Months | Current |
Peer Comparison of Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Flawless Pharma Private Limited | ₹167.18 Cr (FY 2023) | •••• | •••• | 2563.0% | •••• | Mumbai, Maharashtra, India |
| Srini Pharmaceuticals Private Limited | ₹165.56 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Chromo Laboratories India Private Limited | ₹164.91 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Patancheru, Telangana, India |
| Calyx Chemicals and Pharmaceuticals Limited | ₹163.62 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Thane, Maharashtra, India |
| S.V. Labs Private Limited | ₹162.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Vasista Life Sciences Private Limited this company | ₹162.88 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Hyderabad, Telangana, India |
| Syntho Chirals Private Limited | ₹162.38 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Vivin Drugs & Pharmaceuticals Private Limited | ₹161.52 Cr (FY 2023) | •••• | •••• | -25.0% | •••• | Hyderabad, Telangana, India |
| Valentis Laboratories Private Limited | ₹160.96 Cr (FY 2025) | •••• | •••• | 135.0% | •••• | Sangareddy, Telangana, India |
| Everest Organics Limited Listed | ₹160.17 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Medak, Telangana, India |
| Vision Drugs Private Limited | ₹159.84 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Vasista Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited is audited by NAGARAJARAOB for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NAGARAJARAOB | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vasista Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vasista Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2023 | Axis Bank Limited | ₹20 Lakh | Open |
| 29 Mar 2022 | Others | ₹81 Lakh | Open |
| 16 Oct 2018 | Others | ₹10.5 Cr | Open |
| 22 Dec 2020 | Hdfc Bank Limited | ₹11.57 Cr | Satisfied |
| 16 Oct 2020 | Others | ₹1.57 Cr | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2015 | Funding round | ₹50 Lakh | Investors: 4 individuals |
| Mar 2013 | Funding round | ₹99 Lakh | Investors: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vestro Solvents Private Limited | •••• | •••• | •••• |
| Sreeja Chemicals | •••• | •••• | •••• |
| Sri Sai Durga Scientifics | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited has a workforce of 42 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Vasista Life Sciences Private Limited
Vasista Life Sciences has 1 subsidiary company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Vasista Pharma Chem Private Limited | U24297AP2015PTC096994 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Vasista Life Sciences Private Limited
Vasista Life Sciences Private Limited has 12 board changes on record since 2010: 6 appointments and 6 cessations. The latest: Potturi Akhil Varma was appointed as Additional Director on 28 Nov 2022.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vasista Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vasista Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vasista Life Sciences Private Limited
Vasista Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCV2601C1ZW | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vasista Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vasista Life Sciences Private Limited
Vasista Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2010 (16+ years old) and is registered under CIN U24232TG2010PTC067618.
Vasista Life Sciences reported revenue of ₹162.88 Cr for FY 2025 (up 19% YoY).
Vasista Life Sciences has 6 current directors:
- Potturi Narayana Raju - Managing Director
- Ganapathi Raju Venkataappala Narasimha Varma - Director
- Satya Bangara Srirama Chandra Varma Kanumuri - Director
- Potturi Akhil Varma - Additional Director
- Raja Rajeswari Potturi - Director
- Yerramsetty Srinivasan - Director
Vasista Life Sciences reported a net profit of ₹1.05 Cr (net margin 0.6%) and EBITDA of ₹12.4 Cr (EBITDA margin 7.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vasista Life Sciences is 10% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vasista Life Sciences is 36AADCV2601C1ZW, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vasista Life Sciences is U24232TG2010PTC067618. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vasista Life Sciences was incorporated on 19 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vasista Life Sciences has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020.
The peers of Vasista Life Sciences by revenue are Flawless Pharma Private Limited, Srini Pharmaceuticals Private Limited, Chromo Laboratories India Private Limited, Calyx Chemicals and Pharmaceuticals Limited, S.V. Labs Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Potturi Akhil Varma was appointed as Additional Director on 28 Nov 2022. Yerramsetty Srinivasan was appointed as Director on 24 Aug 2021. Potturi Akhil Varma ceased to be Director on 20 Jul 2021. Vasista Life Sciences has 12 board changes on record in total.
Yes, Vasista Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0004270).